As of 2025-05-04, the Intrinsic Value of Cellectar Biosciences Inc (CLRB) is -4.84 USD. This CLRB valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.27 USD, the upside of Cellectar Biosciences Inc is -1,886.99%.
Based on its market price of 0.27 USD and our intrinsic valuation, Cellectar Biosciences Inc (CLRB) is overvalued by 1,886.99%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.84 - -4.84 | -4.84 | -1,886.99% |
| P/E | (14.32) - (29.90) | (23.34) | -8722.2% |
| DDM - Stable | (5.48) - (15.21) | (10.35) | -3922.1% |
| DDM - Multi | (4.34) - (9.96) | (6.11) | -2357.0% |
| Market Cap (mil) | 12.47 |
| Beta | 1.43 |
| Outstanding shares (mil) | 46.08 |
| Enterprise Value (mil) | -10.81 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.04% |
| Cost of Debt | 5.00% |
| WACC | 9.02% |